Cargando…

Unfolding the Role of Stress Response Signaling in Endocrine Resistant Breast Cancers

The unfolded protein response (UPR) is an ancient stress response that enables a cell to manage the energetic stress that accompanies protein folding. There has been a significant recent increase in our understanding of the UPR, how it integrates physiological processes within cells, and how this in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Clarke, Robert, Cook, Katherine L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2015
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4475795/ https://www.ncbi.nlm.nih.gov/pubmed/26157705 http://dx.doi.org/10.3389/fonc.2015.00140

Ejemplares similares

MYC regulates the unfolded protein response and glucose and glutamine uptake in endocrine resistant breast cancer
por: Shajahan-Haq, Ayesha N, et al.
Publicado: (2014)

A Role for Notch Signalling in Breast Cancer and Endocrine Resistance
por: Acar, Ahmet, et al.
Publicado: (2016)

Glutamine metabolism and the unfolded protein response in MYC-driven breast cancer
por: Shajahan-Haq, Ayesha, et al.
Publicado: (2014)

Endoplasmic Reticulum Stress, Unfolded Protein Response, and Cancer Cell Fate
por: Corazzari, Marco, et al.
Publicado: (2017)

PERK, Beyond an Unfolded Protein Response Sensor in Estrogen-Induced Apoptosis in Endocrine-Resistant Breast Cancer
por: Fan, Ping, et al.
Publicado: (2022)

Abrogating endocrine resistance by targeting ERα and PI3K in breast cancer
por: Fox, Emily M., et al.
Publicado: (2012)

Cannibalism, cell survival, and endocrine resistance in breast cancer
por: Clarke, Robert
Publicado: (2011)

The Mitochondrial Unfolded Protein Response as a Non-Oncogene Addiction to Support Adaptation to Stress during Transformation in Cancer and Beyond
por: Kenny, Timothy C., et al.
Publicado: (2017)

Rewiring of the Endocrine Network in Triple-Negative Breast Cancer
por: Li, Kaixuan, et al.
Publicado: (2022)

Endocrine-disrupting chemicals and breast cancer: a meta-analysis
por: Liu, Haiyan, et al.
Publicado: (2023)

Comprehensive Transcriptomic Analysis Reveals Dysregulated Competing Endogenous RNA Network in Endocrine Resistant Breast Cancer Cells
por: Gao, Liang, et al.
Publicado: (2020)

Unfolded protein response signaling impacts macrophage polarity to modulate breast cancer cell clearance and melanoma immune checkpoint therapy responsiveness
por: Soto-Pantoja, David R., et al.
Publicado: (2017)

Case report: Response to endocrine therapy in triple-negative breast cancer metastases with altered hormone receptors
por: Qin, Ruoyan, et al.
Publicado: (2023)

Nuclear Mechanisms Involved in Endocrine Resistance
por: Dittmer, Jürgen
Publicado: (2021)

Effect of unfolded protein response on the immune infiltration and prognosis of transitional cell bladder cancer
por: Yan, Xiaokai, et al.
Publicado: (2021)

Targeting WEE1 Inhibits Growth of Breast Cancer Cells That Are Resistant to Endocrine Therapy and CDK4/6 Inhibitors
por: Fallah, Yassi, et al.
Publicado: (2021)

THU548 The Role Of Sirtuin 3 In Endocrine Therapy Resistant Breast Cancer Cells Response To Fulvestrant
por: de Oliveira, Karla Andrade, et al.
Publicado: (2023)

Blockade of GRP78 sensitizes breast cancer cells to microtubules-interfering agents that induce the unfolded protein response
por: Wang, Jiao, et al.
Publicado: (2009)

Dysregulation of TLR2 Serves as a Prognostic Biomarker in Breast Cancer and Predicts Resistance to Endocrine Therapy in the Luminal B Subtype
por: Wang, Yunmei, et al.
Publicado: (2020)

DGM-CM6: A New Model to Predict Distant Recurrence Risk in Operable Endocrine-Responsive Breast Cancer
por: Lei, Lei, et al.
Publicado: (2020)

Metabolic Adaptations in an Endocrine-Related Breast Cancer Mouse Model Unveil Potential Markers of Tumor Response to Hormonal Therapy
por: Araújo, Rita, et al.
Publicado: (2022)

Notch Signaling Pathway and Endocrine Resistance in Breast Cancer
por: Bai, Jing-Wen, et al.
Publicado: (2020)

The Unfolded Protein Response in Breast Cancer
por: McGrath, Eoghan P., et al.
Publicado: (2018)

The Unfolded Protein Response: At the Intersection between Endoplasmic Reticulum Function and Mitochondrial Bioenergetics
por: Carreras-Sureda, Amado, et al.
Publicado: (2017)

Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance
por: Sisinni, Lorenza, et al.
Publicado: (2019)

The Effects of Endocrine Therapies on Lipid Profiles in Chinese Young Women With Early Breast Cancer
por: Kang, Yi-Kun, et al.
Publicado: (2021)

Neuro-immune-endocrine mechanisms with poor adherence to aromatase inhibitor therapy in breast cancer
por: Huifang, Li, et al.
Publicado: (2022)

The recent progress of endocrine therapy-induced osteoporosis in estrogen-positive breast cancer therapy
por: Xu, Jing, et al.
Publicado: (2023)

A Case Report of Mesothelioma Response to Endocrine Therapy in Synchronous Breast Cancer and Pleural Epithelioid Mesothelioma: A Double Exemestane Effect
por: Pina, Marta, et al.
Publicado: (2022)

Identification of an unfolded protein response-related signature for predicting the prognosis of pancreatic ductal adenocarcinoma
por: Fang, Lishan, et al.
Publicado: (2023)

Experimental models of endocrine responsive breast cancer: strengths, limitations, and use
por: Clarke, Robert, et al.
Publicado: (2021)

Predicting response/resistance to endocrine therapy for breast cancer
por: Miller, WR, et al.
Publicado: (2005)

ESR1 Mutations Are Not a Common Mechanism of Endocrine Resistance in Patients With Estrogen Receptor–Positive Breast Cancer Treated With Neoadjuvant Aromatase Inhibitor Therapy
por: Reinert, Tomás, et al.
Publicado: (2020)

FDXR drives primary and endocrine-resistant tumor cell growth in ER+ breast cancer via CPT1A-mediated fatty acid oxidation
por: Yan, Chaojun, et al.
Publicado: (2023)

Cancer Wars: Significance of Protein Unfolding in Cancer and Its Inhibition with Natural Amphiphilic Substances
por: Lipinski, Boguslaw
Publicado: (2014)

Safety of adjuvant endocrine therapies in hormone receptor–positive early breast cancer
por: Sehdev, S., et al.
Publicado: (2009)

Increased STAT1 Signaling in Endocrine-Resistant Breast Cancer
por: Huang, Rui, et al.
Publicado: (2014)

Axillary Response in Patients Undergoing Neoadjuvant Endocrine Treatment for Node-Positive Breast Cancer: Systematic Literature Review and NCDB Analysis
por: Stafford, Arielle, et al.
Publicado: (2020)

Endoplasmic Reticulum Stress and Unfolded Protein Response Signaling in Plants
por: Manghwar, Hakim, et al.
Publicado: (2022)

Evidence on Efficacy and Safety of Chinese Medicines Combined Western Medicines Treatment for Breast Cancer With Endocrine Therapy
por: Li, Lu, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nu8kt543f541o4c8biohhb2usk